Clinical Trial Update: Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis [Phase 2, Phase 3]

View source ↗

Summary

This ClinicalTrials.gov study in familial adenomatous polyposis evaluated prevention of progression of duodenal adenomas and has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Neoplasms
• Duodenal Polyps
• Familial Adenomatous Polyposis

Snippet

Sponsor: Radboud University Medical Center | Conditions: Familial Adenomatous Polyposis, Duodenal Neoplasms | Phase 2, Phase 3 | Status: COMPLETED